Jazz Pharmaceuticals price target raised to $207 from $171 at Brean Capital – HedgeChatter

Jazz Pharmaceuticals price target raised to $207 from $171 at Brean Capital

26 Feb

Jazz Pharmaceuticals price target raised to $207 from $171 at Brean Capital

Bystocknews JAZZ, stock Comments Off

View todays social media effects on JAZZ

View the latest stocks trending across Twitter. Click to view dashboard

See who Jazz is hiring next, click here to view

Author